Three Main Forces of Medical Industry

For healthcare consumers, as different medical organizations and innovative services participating in the new medical economy, a variety of driving forces could have broad influence on current medical industry. 

At first, it is the M & A boom. In recent, high-profile mergers and acquisitions boom is likely to continue, and the focus will still be gathered on the insurance company, because the regulatory agencies believe that industry consolidation will benefit consumers, especially the healthcare industry. Insurance companies are actively seeking a competitive advantage, such as diversified sources of income, IT infrastructure and powerful data analysis functions. If these large-scale merger plans are approved, they could further stimulate the acquisition of a chain reaction, thereby affecting the entire medical industry. Although the insurance company will be the protagonist under M & A boom in the coming year, entire healthcare industry is also showing a rising trend in mergers and acquisitions activity, which means medical services suppliers have focused on reinforcing the brand. 

Secondly, the drug price have reached boiling point so that modern pharmaceutical industry’s concern is to finding the balance between price and innovation, namely how to price “ just right”. Under the pressure of strong government policies, pharmaceutical companies are considering to apply new ways to get people to agree with the price of drugs. In fact, many factors have contributed to the price rise in this dispute. Since 2006, the rise in the price of brand-name drugs has also been more than the inflation rate, even the price of generic drugs. With many development costs exceed $ 100,000, it is necessary to expand market share for new specialty drugs, which will result in the rising trend of drug price. Value is increasingly important in drug pricing decisions.

Finally, the most important factor is medical consumerism. High-deductible health insurance plans could exist everywhere. Of-pocket expenses of patients are constantly increasing, as well as uncompensated hospital care costs. Faced with such a medical billing and payment system, patients often feel very depressed. Most customers hope to begin to manage their own medical expense manners, using new medical plan that is similar to 401k retirement plan. Such idea has affected the entire industry. Consumers, especially the young, have expressed a strong interest. They prefer to use those plans designed to develop health services. In addition, more and more consumers are responding to the financial adviser of this appeal. 

Taking all the details into consideration, major health issues demands more attentions than before as the development of personalized healthcare, which might contribute to helping consumers make better resource allocation decisions.

About Author

Creative Peptides is specialized in the process development of bioactive peptides. It provides customers with manufacturing services to the peptide manufacturers for the biopharmaceutical market. Visit the site to know more. 

Scientists Successfully Synthesized the Prions

Sometimes in order to understand the mechanism of something, related information needs to be rebuilt; it is also true for prions. Recently, researchers from the Institute of Milan BESTA have successfully assembled artificial prions after mass trails, and at the same time they also devised a way to synthesize prions. Laboratory testing results indicate that the synthetic prions can show similar biological characteristics; relevant research results have been published in the international journals.

Researchers noted the study will help people understand a fact that prions can also cause disease, such as the molecular mechanisms of disease processes like BSE and Creutzfeldt-Jakob disease. Synthetic prions could help researchers to conduct experiments on pathogenic reactions, enabling an accurate control. But the operation of natural prions is not so easy because such prions are very complex and heterogeneous. 

Researchers can easily control the heterogeneity and structural characteristics of those synthetic prions, and these synthetic virus will exhibit the same sequence as natural virus. Clearly, the ultimate goal of researchers is to identify how to block prions infection and develop new therapies to resist the occurrence of related diseases. In this study, researchers first successfully synthesized the prions in mice and identified involved molecular mechanism in mice caused by pathogenic prions, which might help understand the pathogenesis of natural prions. When they are analyzing the specific features of prion properties, they have found synthetic prions that could cause BSE and CJD are very similar to natural prions. 

The researchers concluded that such research has been carried out for a long time and the in-depth discovery will be completed in the future, which will probably promote natural prions research on humans. Currently, the study has benefited the development of new therapies for human neurodegenerative prion-caused disease. In addition, researchers are considering whether it’s available to synthesize key molecules that cause Parkinson’s disease or amyloid triggering Alzheimer’s disease, which could help develop new therapies to treat diseases such as neurodegenerative disorders. 

About Author

Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. It provides customers with manufacturing services to the peptide manufacturers for the biopharmaceutical market. Visit http://www.creative-peptides.com/ to know more about Creative Peptides.